Bioxytran, Inc (BIXT): Revenue

Annual figures by period end, from SEC filings.

Older than the company's other figures. The latest Revenue is for the year ended 2017-12-31, while the company's latest annual report covers the year ended 2025-12-31. Its later filings do not report this line under the concept TickerFacts maps.

$191.1K
Year ended 2017-12-31
-11.5%
3-year compound annual growth
-9.4%
5-year compound annual growth
$417.3K2010-12-31: $16.1K2011-12-31: $76.3K2012-12-31: $312.9K2013-12-31: $417.3K2014-12-31: $275.6K2015-12-31: $255.8K2016-12-31: $246.5K2017-12-31: $191.1K$191.1K
2010-12-31 Revenue (USD) 2017-12-31
Period endedRevenueChange YoYSource filing
2017-12-31$191.1K-22.5%2018-04-02, From 2017-01-01
2016-12-31$246.5K-3.6%2018-04-02, From 2016-01-01
2015-12-31$255.8K-7.2%2017-03-31, From 2015-01-01
2014-12-31$275.6K-34.0%2016-09-20, From 2014-01-01
2013-12-31$417.3K+33.4%2015-04-10, From 2013-01-01
2012-12-31$312.9K+310.1%2014-04-14, From 2012-01-01
2011-12-31$76.3K+372.9%2013-04-15, From 2011-01-01
2010-12-31$16.1Kn/a2012-12-31, From 2010-01-01